From Donation to Innovation: New Blood-Derived Products
Transfusion Medicine and Hemotherapy · 21.05.2026 · 1-14
DOI: 10.1159/000552492 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transfusion Medicine and Hemotherapy, online erschienen am 21.05.2026. Verfasst von Kerstin Wendland und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background: Recent advances in transfusion medicine are transforming donated blood into a versatile source for a new generation of therapeutic products. This narrative review summarizes emerging innovations across plasma, red blood cells (RBCs), platelets, donor stem cells, and cord blood. Summary: Developments in plasma technology, including dried plasma, isoagglutinin-depleted universal plasma, and protein-derived products aim to enhance safety, stability, and clinical applicability. RBC innovations focus on improved preservation, engineered or artificial oxygen carriers, extracellular vesicle-based products, and strategies for producing universal blood cells. Platelet-derived products such as platelet-rich plasma, platelet lysates, and platelet extracellular vesicles are expanding applications beyond hemostasis into regenerative medicine. Advances in donor stem cell technologies offer new pathways for scalable, donor-independent production of blood cells. Additionally, cord blood (CB)-derived red cells represent a promising new product with unique biological properties. Key Message: Together, these developments illustrate a shift toward more engineered, customizable, and sustainable blood-derived therapeutics, with the potential to address clinical needs unmet by traditional transfusion components.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany.
- Center for Orthopaedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Greifswald, Germany.
Zitieren
APA
Wendland, K., Selleng, K., & Aurich, K. (2026). From Donation to Innovation: New Blood-Derived Products. Transfusion Medicine and Hemotherapy, 1-14. https://doi.org/10.1159/000552492
Vancouver
Wendland K, Selleng K, Aurich K. From Donation to Innovation: New Blood-Derived Products. Transfusion Medicine and Hemotherapy. 2026:1-14. doi:10.1159/000552492
BibTeX
@article{Wendland2026,
author = {Wendland, Kerstin and Selleng, Kathleen and Aurich, Konstanze},
title = {From Donation to Innovation: New Blood-Derived Products},
journal = {Transfusion Medicine and Hemotherapy},
year = {2026},
pages = {1--14},
doi = {10.1159/000552492}
}
EUVIMED